DEVELOPMENTS IN THERAPY FOR EXTENSIVE-DISEASE SMALL-CELL LUNG-CANCER

被引：0
|
作者：
COMIS, RL
机构：
来源：
SEMINARS IN ONCOLOGY | 1992年 / 19卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：45 / 50
页数：6
相关论文
共 50 条
  • [1] PALLIATIVE THERAPY - EXTENSIVE SMALL-CELL LUNG-CANCER
    LOEHRER, PJ
    [J]. SEMINARS IN ONCOLOGY, 1995, 22 (02) : 40 - 44
  • [2] Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451
    Owonikoko, Taofeek K.
    Park, Keunchil
    Govindan, Ramaswamy
    Ready, Neal
    Reck, Martin
    Peters, Solange
    Dakhil, Shaker R.
    Navarro, Alejandro
    Rodriguez-Cid, Jeronimo
    Schenker, Michael
    Lee, Jong-Seok
    Gutierrez, Vanesa
    Percent, Ivor
    Morgensztern, Daniel
    Barrios, Carlos H.
    Greillier, Laurent
    Baka, Sofia
    Patel, Miten
    Lin, Wen Hong
    Selvaggi, Giovanni
    Baudelet, Christine
    Baden, Jonathan
    Pandya, Dimple
    Doshi, Parul
    Kim, Hye Ryun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (12) : 1349 - +
  • [3] KINETICALLY SCHEDULED THERAPY FOR EXTENSIVE SMALL-CELL LUNG-CANCER
    CLAMON, GH
    MCFADDEN, DB
    WEISENFELD, M
    BELL, S
    [J]. CANCER CLINICAL TRIALS, 1981, 4 (02) : 159 - 162
  • [4] Extensive-disease small-cell lung cancer: The thrill of victory; The agony of defeat
    Aisner, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 658 - 665
  • [5] Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer
    Kim, Young Saing
    Park, Se Hoon
    Kyung, Sun Young
    Sym, Sun Jin
    Lee, Sang Pyo
    Park, Jeong Woong
    Jung, Sung Hwan
    Park, Jinny
    Cho, Eun Kyung
    Lee, Jae Hoon
    Shin, Dong Bok
    [J]. MEDICAL ONCOLOGY, 2011, 28 (01) : 342 - 350
  • [6] Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer
    Young Saing Kim
    Se Hoon Park
    Sun Young Kyung
    Sun Jin Sym
    Sang Pyo Lee
    Jeong Woong Park
    Sung Hwan Jung
    Jinny Park
    Eun Kyung Cho
    Jae Hoon Lee
    Dong Bok Shin
    [J]. Medical Oncology, 2011, 28 : 342 - 350
  • [7] Paclitaxel/epirubicin/etoposide in patients with extensive-disease small-cell lung cancer (SCLC)
    Baldini, E
    Chella, A
    Del Freo, A
    Gragnani, F
    Angeletti, CA
    Conte, PF
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S257 - S258
  • [8] A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer
    Shibayama, Takuo
    Hotta, Katsuyuki
    Takigawa, Nagio
    Tada, Atsuhiko
    Ueoka, Hiroshi
    Harita, Shingo
    Kiura, Katsuyuki
    Tabata, Masahiro
    Segawa, Yoshihiko
    Nogami, Naoyuki
    Kuyama, Shoichi
    Shinkai, Tetsu
    Tanimoto, Mitsune
    [J]. LUNG CANCER, 2006, 53 (02) : 189 - 195
  • [9] A Prognostic Model Integrating Immunohistochemistry Markers for Extensive-Disease Small-Cell Lung Cancer
    Fu, R.
    Zhang, C.
    Zhang, J.
    Yang, J.
    Zhou, Q.
    Yang, X.
    Wu, Y.
    Zhong, W.
    Huang, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S794 - S795
  • [10] CARBOPLATIN AND ETOPOSIDE IN EXTENSIVE SMALL-CELL LUNG-CANCER
    VIREN, M
    LIIPPO, K
    OJALA, A
    HELLE, L
    HINKKA, S
    HUOVINEN, R
    JAKOBSSON, M
    JARVINEN, M
    PALOHEIMO, S
    SALMI, R
    SALOMAA, ER
    NIKKANEN, V
    [J]. ACTA ONCOLOGICA, 1994, 33 (08) : 921 - 924
12345